Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-11-17
1997-04-29
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 424851, A61K 3816
Patent
active
056249047
ABSTRACT:
Macrophage scavenger receptor protein or active fragments thereof bind specifically to the lipoteichoic acid residues on the Gram-positive bacterial cell wall. This protein or active fragments thereof can be used in a variety of methods including methods to specifically purify lipoteichoic acid, to preferentially label or detect lipoteichoic acid or lipoteichoic acid-containing compounds or cells, and to treat patients having Gram-positive bacterial infections such as septicemia and associated pathophysiological states such as septic shock.
REFERENCES:
patent: 5234912 (1993-08-01), Marra et al.
Acton, S., et al, "The collagenous domains of macrophage scavenger receptors and complement component Clq mediate their similar, but not identical, binding specificities for polyanionic ligands", 268 J. Biol. Chem. 3530-3537 (1993). This paper was published less than one year before the filing date of the present application.
Ashkenas, J., et al., "Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors", J. Lipid Res., 983-1000 (1993). This paper was published less than one year before the filing date of the present application.
Brown, M.S., and J.L. Goldstein, "Lipoprotein metabolism in the macrophage: mplications for cholesterol deposition in atherosclerosis", 52 Ann. Rev. Biochem. 223-261 (1983).
Caparon, M.G., et al., "Role of M protein in adherence of group A streptococci", 59 Infect. Immun. 1811-1817 (1991).
Clackson, T., et al., "Making Antibody Fragments Using Phase Display Libraries", 352 Nature 624-628 (1991).
Dale, D.C., and R.G. Petersdorf, "Septic Shock", Harrison's Principles of Internal Medicine 474-478, 11th ed., E. Braunwald et al. eds. (1987).
Daniel, T.O., et al., "Visualization of lipoprotein receptors by ligand blotting", 258(7) J. Biol. Chem. 4606-4611 (1983).
Daugherty, B.L., et al., "Polymerase chain reaction facilitates the cloning, CDR-grafting and rapdi expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins", 19(9) Nucl. Acids Res. 2471-2476 (1991).
Doi, T., et al., "Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors", 268(3) J. Biol. Chem. 2126-2133 (1993). This paper was published less than one year before the filing date of the present application.
Dresel, H.A., et al., "Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver; one or two receptors?", 6 Embo. J. 319-326 (1987).
Fischer, W., "Physiology of lipoteichoic acids in bacteria", 29 Adv. Microb. Physiol. 233-302 (1988).
Freeman, M., et al., "An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors", 87 Proc. Natl. Acad. Sci. (USA) 8810-8814 (1990).
Goldstein, J.L., et al., "Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition", 76(1) Proc. Natl. Acad. Sci. USA 333-337 (1979).
Goldstein, J.L., and M.S., Brown, "Familial Hypercholesterolemia", The Metabolic Basis of Inherited Disease, 672-713 Stanbury, J.B., et al. eds New York 1983.
Hampton, R.Y., et al., "Lipid a binding sites in membrances of macrophage tumor cells", 263 J. Biol. Chem. 14802-14807 (1988).
Hampton, R.Y., et al., "Recognition and plasma clearance of endotoxin by scavenger receptors", 353 Nature 342-344 (1991).
Holm, S.E., "Gram-positive microorganisms in sepsis", Scand. J. Infec. Dis., Suppl. 68-77 (1982).
Huang, S.C., et al., "Human recombinant monoclonal antibodies to 60kD Ro Autoantigen", Abstract 167, p. 566, American College of Rheumatology, 57th Annual Scientific Meeting, San Antonio (1993).
Kessler, R.E., et al., "Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci", 150 J. Exp. Med. 1498-1509 (1979).
Kodama, T., et al., "Type I macrophase scavenger receptor contains .alpha.-helical and collagen-like coiled coils", 343 Nature 531-535 (1990).
Krieger, M., "Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor", 17(4) Trends Biochem. Sci, 141-146 (1992).
Krieger, M., et al., "Molecular flypaper, host defense, and atherosclerosis, Structure, binding properties, and functions of macrophage scavenger receptors", 268(7) J. Biol. Chem. 4569-4572 (1993).
Laemmli, U.K., "Cleavage of structural protein during the assembly of the head of bacteriophage T4", 227 Nature 680-685 (1970).
McCafferty, J., et al., "Phage antibodies; filamentous phage displaying antibody variable domains", 348 Nature 552-554 (1990).
Mahlev, R.W., et al., "Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins", 348 Ann. N.Y. Acad. Sci. 265-280 (1980).
Nagelkerke, J.F., and T.J. van Berkel, "Rapid transport of fatty acids from rat liver endothelial to parenchymal cells after uptake of cholesteryl ester-labeled acetylated LDL", 875 Biochim. Biophys. Acta 593-598 (1986).
Norman, D.J., et al., "Consensus statement regarding OKT3-induced cytokine release syndrome and human antimouse antibodies", 25(2)(Supp. 1) Transplant Proc. 89-92 (1993).
Ofek, I., et al., "Cell membrane-binding properties of group A streptococcal lipoteichoic acid", 141 J. Exp. Med. 990-1003 (1975).
Pitas, R.E., et al., "Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells", 100 J. Cell Biol. 103-117 (1985).
Raetz, C.R.H., et al., "Gram-negative endotoxin; A biologically active lipid", 53 Cold Spring Harbor Symp. Quant. Biol. 973-982 (1988).
Resnick, D., et al., "Secreted extracellular domains of macrophase scavenger receptors form elongated trimers which specifically bind crocidolite asbestos", 268 (5) J. Biol. Chem. 3538-3545 (1993).
Rohrer, L., et al., "Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II", 343 Nature 570-572 (1990).
Sastry, K., and R.A. Ezekowitz, "Collectins: pattern recognition molecules involved in first line host defense", 5(1) Curr. Opin. Immunol. 59-66 (1993).
Schneider, W.J., et al., "Partial purification and characterization of the low density lipoprotein receptor from bovine adrenal cortex", 255 J. Biol. Chem. 11442-11447 (1980).
Simpson, W.A., et al., "Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin", 255 J. Biol. Chem. 6092-6097 (1980).
Steinberg, D., et al., "Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity", 320(14) N. Engl. J. Med. 915-924 (1989).
Sutcliffe, I.C., and N. Shaw, "Atypical lipoteichoic acids of gram-positive bacteria", 173 J. Bacteriol. 7065-7069 (1991).
Van Berkel, T.J.C., et al., "Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells", 266(4) J. Biol. Chem. 2282-2289 (1991).
Werner, R.G., et al., "Safety and economic aspects of continuous mammalian cell culture", 22 J. Biotechnology 51-68 (1992).
Wessels, M.R., et al., "Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci", 88 Proc. Natl. Acad. Sci. 8317-8321 (1991).
Wicken, A.J., and K.W. Knox, "Lipoteichoic acids: A new class of bacterial antigen", 187 Science 1161-1167 (1975).
Bone, Roger C, Annals of Internal Medicine, vol. 115(6), pp. 457-469, 1991.
Kilbourn, Robert C. et al., Jour. of The National Cancer Institute, vol. 84(11), pp. 827-831, 1992.
Natanson, Charles et al., Annals of Internal Medicine, vol. 120(9), pp. 771-783, 1994.
The Economist, "Panic in the Petri Dish", pp. 61-62, Jul. 23, 1994.
Cross, Alan S et al., Infection and Immunity, vol. 61, No. 7, pp. 2741-2747, Jul. 1993.
Petros, ANdy et al., The Lancet, vol. 338, pp. 1557-1448, 1991.
Hampton et al., J. Biol. Chem., vol. 266(29), pp. 19499-19509, 1991.
Van Lenten et al., I. Immunology, vol. 134(6). pp. 3718-3721, 1985.
Joiner Keith A.
Krieger Monty
Massachusetts Institute of Technology
Sayala Chhaya D.
Yale University
LandOfFree
Method for treating gram positive septicemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating gram positive septicemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating gram positive septicemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705659